Translational Stroke Research · 2012 · 92 citations · 26 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceMolecular PharmacologyNeuropharmacologyAcute Ischemic StrokeCerebrovascular DiseaseCerebrovascular PhysiologyNeuroprotectionStrokeStroke PharmacotherapyAcute Ischemic Stroke TreatmentCerebral Ischemia PharmacotherapyIschemic Stroke PathophysiologyPlasminogen ActivatorsRodent Cerebral IschemiaStroke ModelsStroke NeuroprotectionSwelling
Glibenclamide improves outcomes in rat models of stroke, with treatment as late as 6 h after onset of ischemia shown to be beneficial. Because the molecular target of glibenclamide, the sulfonylurea receptor 1 (Sur1)-regulated NC(Ca-ATP) channel, is upregulated de novo by a complex transcriptional mechanism, and the principal pathophysiological target, brain swelling, requires hours to develop, we hypothesized that the treatment window would exceed 6 h. We studied a clinically relevant rat model of stroke in which middle cerebral artery occlusion (75% < reduction in LDF signal ≤90%) was produced using an intra-arterial occluder. Recanalization was obtained 4.5 h later by removing the occluder. At that time, we administered recombinant tissue plasminogen activator (rtPA; 0.9 mg/kg IV over 30 min). Immunolabeling showed modest expression of Sur1 5 h after onset of ischemia, with expression increasing 7- to 11-fold (P < 0.01) by 24 h. Rats were administered either vehicle or glibenclamide (10 μg/kg IP loading dose plus 200 ng/h by constant subcutaneous infusion) beginning 4.5 or 10 h after onset of ischemia. In rats treated at 4.5 or 10 h, glibenclamide significantly reduced hemispheric swelling at 24 h from (mean ± SEM) 14.7 ± 1.5% to 8.1 ± 1.6% or 8.8 ± 1.1% (both P < 0.01), respectively, and significantly reduced 48-h mortality from 53% to 17% or 12% (both P < 0.01), and improved Garcia scores at 48 h from 3.8 ± 0.62 to 7.6 ± 0.70 or 8.4 ± 0.74 (both P < 0.01). We conclude that, in a clinically relevant model of stroke, the treatment window for glibenclamide extends to 10 h after onset of ischemia.
26
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
Gregory J. del Zoppo, Klaus Poeck, Michael S. Pessin et al. · Annals of Neurology · 1992 · 1K citations
Medicine, Neurosurgery, Surgery +17
Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke
J. Marc Simard, Mingkui Chen, Kirill V. Tarasov et al. · Nature Medicine · 2006 · 455 citations · Full text
Medicine, Neurology, Neuroscience +16
Kinetics of Proton Transport in Water
A. A. Kornyshev, Alexey Kuznetsov, Eckhard Spohr et al. · The Journal of Physical Chemistry B · 2003 · 272 citations
Natural Sciences, Chemistry, Physics +17